Clinical Trial Grants | Overview
Full Application due: Nov. 16, 2018
All materials should be submitted to the TRP
The goal of the Mooney Family Initiative for Translational and Clinical Studies in Rare Diseases award (TCSRD) is to assist investigators in the execution of their early phase human trials (including in particular first in human and pilot/feasibility studies), to allow investigators to more rapidly pursue their research which could ultimately impact the lives of pediatric patients suffering from serious or life-threatening diseases. By providing extraordinary clinical trial support to an investigator, this program seeks to enhance the translation of discovery science such that this science can have a more immediate global impact in rare pediatric diseases. The Translational Research Program (TRP) has created this new initiative to provide support to investigators in three spheres:
- Clinical trial costs on selected, peer-reviewed protocols.
- Clinical care costs for patients participating in selected clinical trials who do not have insurance coverage and no means to pay.
- Transportation and housing cost for families outside of New England, including international patients.